Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance

ADMA Biologics IncTrade
Vanguard Global ex-US Real Estate Index Fd ETFTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.51. The key difference: Vanguard Global ex-US Real Estate Index Fd ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAVNQI
Market Cap
$2.22B
Sector
Health
52-Week High
$20.38$50.76
52-Week Low
$7.60$43.26
Enterprise Value
$2.29B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.83, up 0.82% today, with strong profitability metrics including a 32.98% net income margin and 41.9% ROE. Recent earnings show mixed results, with a beat in Q4 2025 but misses in Q1 and Q2 2026. Technical indicators are bullish overall, though RSI levels suggest overbought conditions. The stock faces significant legal headwinds from multiple securities fraud class actions filed in August 2026.

The outlook is cautiously optimistic given solid fundamentals and analyst support, but legal risks and recent earnings misses pose near-term challenges. Upside potential exists if the company can maintain profitability and resolve litigation, while downside risks include prolonged legal proceedings and execution missteps.

Vanguard Global ex-US Real Estate Index Fd ETF

VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $45.72, up 0.35% with a bullish technical signal from moving averages. The ETF provides diversified international real estate exposure across 30+ countries outside the U.S. with a competitive expense ratio and higher dividend yield compared to domestic REIT ETFs. Recent institutional activity shows Balefire LLC reduced its position by 78.7% in Q2 2026.

The fund offers international real estate diversification benefits but faces currency risk and potential underperformance versus U.S. REITs. Current technical momentum supports near-term upside, though investors should weigh the trade-off between higher yield and historical total return lag against domestic alternatives.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Vanguard Global ex-US Real Estate Index Fd ETF

The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).

Read more on VNQI